Pages Menu

Posted by on Feb 12, 2016 in AdvisorShares, Impact

AdvisorShares Turns Our Attention to Rare Cancer Research – CYCLE FOR SURVIVAL

AdvisorShares Turns Our Attention to Rare Cancer Research – CYCLE FOR SURVIVAL

According to the National Institutes of Health (NIH), a “rare cancer” is one with a prevalence of fewer than 200,000 affected individuals in the United States. But when you put all of these rare cancer types together, they account for approximately half of all cancer diagnoses. Research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality.

Cycle for Survival‘s indoor team cycling events raise funds that are critical for rare cancer research. 100% of every donation to Cycle for Survival is directly allocated to research at Memorial Sloan Kettering Cancer Center within six months of the events. Thanks to the tremendous efforts of participants, donors, and supporters, Cycle for Survival has raised over $80 million for rare cancer research, and funded 100+ clinical trials and research studies.

On Sunday, March 6th from 1:00pm to 5:00pm AdvisorShares very own team, AlphaSquad, will Join the Battle! We are committed to ensuring rare cancer patients get new and better treatment options. Want to know who’s riding? Check out our Team Page here. And, after March 6th, check back for pictures and our reflections on the event!

The AlphaBaskets blog provides frequent market insight and commentary by AdvisorShares Investments, LLC, created by AdvisorShares and other leading active managers.  AdvisorShares Investments is an SEC-registered investment adviser and the investment adviser to the AdvisorShares actively managed ETFs. The views expressed on AlphaBaskets should not be taken as investment advice or a recommendation for any of the actively managed ETFs advised by AdvisorShares.